Clinical significance of decreased or loss of ABO blood group expression in acute myeloid leukaemia: A single-centre retrospective study.
Jay Ho HanHowon LeeJae Kwon KimJaeeun YooKyuho ParkDong Wook JekarlYonggoo KimPublished in: Vox sanguinis (2024)
AML with decreased expression or loss of ABO blood group showed better early survival during D90. Transfusion support for this subgroup of AML patients should be meticulously performed considering serum typing.
Keyphrases
- acute myeloid leukemia
- poor prognosis
- end stage renal disease
- ejection fraction
- newly diagnosed
- liver failure
- binding protein
- cardiac surgery
- dendritic cells
- peritoneal dialysis
- long non coding rna
- respiratory failure
- clinical trial
- immune response
- patient reported outcomes
- acute lymphoblastic leukemia
- sickle cell disease
- phase iii
- free survival
- patient reported
- open label
- mechanical ventilation